Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 4,674 shares at $22.89 ($107K) on 2024-08-13, disclosed to the SEC on 2024-08-15.
Seasonal sale ($107k) by Chief Medical Officer — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.89 | 2,337 | $53K | 50.0% |
| 2 | $22.89 | 2,337 | $53K | 50.0% |
| Total | $22.89 avg | 4,674 | $107K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |
| DNLI | SELL | 2024-01-12 | $178K | — | Filing → |